AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
ImmuPharma Shows Remarkable Growth – What’s Driving the Surge?
January 13, 2025 06:41 AM AEDT| By Team Kalkine MediaHeadlines,ImmuPharma’s stock sees significant increase,Impressive trading volume and investor interest,Factors contributing to stock’s positive momentum,ImmuPharma plc,(LON:IMM),has seen a noticeable rise in its stock price recently, reflecting stron...
Nuformix Sees Notable Stock Price Surge Amid Increased Trading Activity
January 13, 2025 05:25 AM AEDT| By Team Kalkine MediaHeadlines,Nuformix,(LON:NFX),sees notable rise in stock price,Major increase in trading volume boosts momentum,Positive factors contributing to share price surge,Nuformix has recently experienced a significant uptick in its stock price, showing impre...
Aegros Bidco Announces Recommended Acquisition of Alliance Pharma
January 10, 2025 07:18 PM AEDT| By Team Kalkine MediaHighlights,Cash Offer,: Each Scheme Shareholder is entitled to receive 62.5 pence in cash per Scheme Share, valuing Alliance at approximately £349.7 million.,Premium Offer,: The Cash Offer represents a significant premium of 40.9% to the closing pric...
NIOX Group Plc (LON:NIOX) Faces Decline Amid Trading Volatility
January 09, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,NIOX Group Plc (NIOX) sees a 2.3% decline in stock price on Wednesday.,260,541 shares exchanged hands, representing a 32% drop in trading volume.,Insider transactions reflect mixed sentiment on company stock.,NIOX Group Plc (LON:NIOX) expe...
Bioventix PLC (LON:BVXP) Stock Shows Volatility with Recent Movement Below 200-Day Moving Average
January 09, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Bioventix (BVXP) shares dropped below their 200-day moving average.,The stock traded as low as GBX 3,200 during the session.,Despite the movement, the stock closed with a slight 1.7% increase.,Bioventix PLC (LON:BVXP), a company renowned f...
Spire Healthcare Group (LON:SPI) Sees Positive Momentum as Stock Surpasses 50-Day Moving Average
January 09, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Spire Healthcare Group shares (SPI) surpass the 50-day moving average.,The stock reached a high of GBX 230 during Wednesday's trading.,Market capitalization stands at £910.61 million, with a solid price-to-earnings ratio.,Spire Healthcare...
Breakthrough Advancements in Autoimmune Disease Research by ImmuPharma PLC (LON:IMM)
January 09, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma's breakthrough findings,offer novel insights into autoimmune disease mechanisms.,P140 therapy's potential,enables earlier diagnostics and more targeted treatment responses.,Expansion of intellectual property,strengthens ImmuPhar...
Abingdon Health (LON:ABDX) Sees Modest Stock Rise Amid Increased Trading Volume
January 08, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Abingdon Health's (LON:ABDX) shares rose by 0.8% during recent trading.,Trading volume surged by 82%, surpassing the average daily activity.,The company continues to lead in the global rapid testing sector.,Abingdon Health Plc (LON:ABDX),...
CVS Group (LON:CVSG) Stock Dips Below 200-Day Moving Average
January 08, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Stock Movement,CVS Group shares slipped below the 200-day moving average, closing at GBX 827.,Financial Metrics,The company maintains a current ratio of 1.09 and a market cap of £592.57 million.,Operational Focus,CVS Group operates across...
Mixed Analyst Views on GSK Amid Stock Adjustments and Market Activity
January 08, 2025 05:18 AM AEDT| By Team Kalkine MediaHeadlines,Key Developments in GSK,(LON:GSK),Stock,Analysts Provide Mixed Views on GSK Performance,GSK’s Stock Activity and Recent Adjustments,GSK is experiencing a shift in its stock ratings from key financial institutions. JPMorgan Chase & Co. recen...
Haleon plc: A Snapshot of Recent Stock Movements and Strategic Insights
January 07, 2025 09:54 PM AEDT| By Team Kalkine MediaHeadlines,Haleon plc,(LON:HLN),witnessed a slight dip in its stock performance during Monday's trading session.,The company's financial health, insider transactions, and trading activity continue to draw attention.,Haleon maintains its focus on long-...
Poolbeg and HOOKIPA Provide Update on Potential Combination and Fundraise
January 07, 2025 07:52 PM AEDT| By Team Kalkine MediaHighlights,Gilead Sciences Supports Proposal:,Significant HOOKIPA shareholder, Gilead Sciences, intends to vote in line with the HOOKIPA Board's recommendation and participate in the proposed $30 million+ fundraise.,Fundraise Details Amended:,HOOKIPA...
GSK Secures FDA Breakthrough Therapy Designation for Osteosarcoma Treatment
January 07, 2025 07:05 PM AEDT| By Team Kalkine MediaHighlights,Breakthrough Therapy Designation:,GSK5764227 (GSK'227), a B7-H3-targeted ADC, receives FDA recognition for its potential to treat relapsed or refractory osteosarcoma, offering hope to patients with limited options.,Strong Clinical Backing:...
ConvaTec Group (LON:CTEC) Experiences 0.8% Increase in Share Price Amid Market Activity
January 07, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ConvaTec Group (CTEC) saw a 0.8% increase in share price on Monday.,Approximately 2.56 million shares were traded, reflecting an 8% decrease in trading volume.,The company's debt-to-equity ratio stands at 85.32, signaling financial leverag...
Tristel (LON:TSTL) Stock Surpasses 50-Day Moving Average, Signaling Positive Momentum
January 07, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Tristel (TSTL) stock surpasses its 50-day moving average.,Shares trade up by 1.0% with strong session highs.,The company declares a dividend, marking a notable increase.,Tristel plc (LON:TSTL), a company recognized for its infection preven...
GSK's Nucala (Mepolizumab) Approved for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in China
January 03, 2025 06:42 PM AEDT| By Team Kalkine MediaHighlights,GSK's Nucala (mepolizumab) has been approved by China's National Medical Products Administration for CRSwNP treatment.,The approval follows positive results from Phase III trials, demonstrating its efficacy in patients with inadequately co...
Poolbeg Pharma (LON:POLB) Shares Decline by 0.7% Amid Reduced Trading Volume
January 03, 2025 01:09 AM AEDT| By Team Kalkine MediaHighlights,Price Movement,Poolbeg Pharma (LON:POLB) shares dipped 0.7%, closing at GBX 7.10.,Trading Volume,Daily trade volume fell by 76% compared to the average.,Market Metrics,The stock reflects a 50-day average of GBX 7.68 and a market cap of £35...
Roquefort Therapeutics Signs Term Sheet for Sale of Lyramid to Pleiades Pharma
January 02, 2025 06:26 PM AEDT| By Team Kalkine MediaHighlights:,Sale of Lyramid,: Roquefort Therapeutics has agreed to sell its subsidiary Lyramid to Pleiades Pharma for a minimum of US$10 million, including equity in Pleiades and potentially upfront cash.,Contingencies and Exclusivity,: The deal is c...
Arecor Therapeutics Advances AT351 with Exclusive Global Licensing Agreement
December 30, 2024 10:13 PM AEDT| By Team Kalkine MediaHighlights,Exclusive Licensing Secured:,Arecor licenses worldwide rights for AT351 to an undisclosed partner, supported by its Arestat platform.,Milestone-Based Payments:,Agreement includes upfront payment, development milestones, and royalties on gl...
Hemogenyx Pharmaceuticals Advances in Leukaemia Treatment with Phase I Clinical Trial of HG-CT-1
December 30, 2024 10:13 PM AEDT| By Team Kalkine MediaHighlights,Initiation of Clinical Trial:,Hemogenyx Pharmaceuticals begins Phase I trial for HG-CT-1, targeting recurrent acute myeloid leukaemia (AML).,Focus on Safety and Efficacy:,Trial evaluates safety, survival rates, and clinical responses in re...
AI on the Rise: A Look at Top AI Companies and Their Stocks